RecruitingNCT04255264

Adipose Inflammation and Diabetes (FAB)

Adipose Tissue Inflammation and Diabetes Development (Fettvävsinflammation Och Diabetesutveckling)

Sponsor

Göteborg University

Enrollment

18 participants

Start Date

Aug 1, 2019

Study Type

OBSERVATIONAL

Conditions

Obese

Summary

The study investigates whether the addition of resolution molecules can inhibit inflammation and insulin resistance in human tissue taken from obese individuals, and whether the results of these studies correlate with patient-specific resolution phenotypes.

Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria5

BMI 30-40 kg/m2
Ptos (i.e. excess skin) > 3 cm
Patient underwent gastric bypass surgery >2 years ago
Patient has had a stable weight ≥6 months at the time of operation
Patient does not smoke (min 6 weeks prior to surgery)

Exclusion Criteria5

Patients who do not understand spoken and written Swedish
American Society of Anesthesiologists (ASA) classification ≥ 3
Neurological, orthopedic or rheumatologic injury or illness affecting physical ability
Preoperatively known hernia requiring surgical operation
Severe mental illness

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Sahlgrenska university hospital

Gothenburg, Västra Götaland County, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04255264

Related Trials

A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants

NCT072195891 location

A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese

NCT074115601 location